Organon (TICKER: OGN) Benchmark And Performance Data

there are 10 of samples in the benchmark for Organon in year 2022 in 2022. The total inventory for Organon was $915,000,000.00 in 2021. The total inventory for Organon was $913,000,000.00 in 2020. The total inventory for Organon was $1,071,000,000.00 in 2019. The sales, general, and administrative (SGA) for Organon was $2,013,000,000.00 in 2018. The sales, general, and administrative (SGA) for Organon was $1,668,000,000.00 in 2021. The sales, general, and administrative (SGA) for Organon was $1,443,000,000.00 in 2019. The sales, general, and administrative (SGA) for Organon was $1,356,000,000.00 in 2020. The sales, general, and administrative (SGA) for Organon was $$1,704,000,000 in 2022. The revenue volatility for Organon was 18.56% in 2022. The market capitalization for Organon was $7,104,397,943.00 in 2018. The market capitalization for Organon was $5,984,240,640.00 in 2019. The market capitalization for Organon was $5,318,370,080.00 in 2020. The market capitalization for Organon was $4,436,666,052.00 in 2021. The market capitalization for Organon was $$4,197,000,000 in 2022. The gross revenue for Organon was $9,777,000,000.00 in 2018. The gross revenue for Organon was $7,777,000,000.00 in 2019. The gross revenue for Organon was $6,532,000,000.00 in 2020. The gross revenue for Organon was $6,304,000,000.00 in 2021. The gross revenue for Organon was $$6,174,000,000 in 2022. The gross margin for Organon was $27.62% in 2022. The days sales outstanding for Organon was 84 days in 2022. The days payable outstanding for Organon was 200 days in 2022. The days of inventory for Organon was $153 in 2022. The cost of goods sold (COGS) for Organon was 37.16% in 2022. The cost of goods sold (COGS) for Organon was $4,693,000,000.00 in 2018. The cost of goods sold (COGS) for Organon was $2,382,000,000.00 in 2021. The cost of goods sold (COGS) for Organon was $2,274,000,000.00 in 2019. The cost of goods sold (COGS) for Organon was $2,119,000,000.00 in 2020. The cost of goods sold (COGS) for Organon was $$2,294,000,000 in 2022. The cash to cash cycle time for Organon was 37 in 2022. The annual percentage growth rate of Organon was 0.02% in 2022. Organon in its benchmark peer group, had rank 9 days for days sales outstanding in 2022. Organon in its benchmark peer group, had rank 7 days for days of inventory in 2022. Organon in its benchmark peer group, had rank 2 for sales growth in 2022. Organon in its benchmark peer group, had rank 2 for cash to cash cycle time in 2022. Organon in its benchmark peer group, had rank 10 for gross revenue in 2022. Organon in its benchmark peer group, had rank 10 for cost of goods sold as a percent of revenue in 2022. Organon headquarters region is East. Organon has ticker symbol OGN. Organon has the following profile: Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally.. Organon has primary indstury Drug Manufacturers - General. Organon had a $$31,176,000,000 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Organon had Organon, and Eli Lilly, and AbbVie, and Pfizer, and Bristol-Myers Squibb, and Amgen, and Gilead Sciences, and Biogen, and Johnson & Johnson, and Merck benchmark peer companies for its SIC code in 2022. Organon had 4.22% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Organon had 283 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Organon had 24 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Organon had 2.96% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Organon had 18 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Organon had 10.30% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Organon had 0.01% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Organon had - number of employees in 2022. Organon can reduce overall cost by $$1,042,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Organon can reduce inventory with practices including SKU Reduction in 2022. Organon can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Organon can reduce inventory with practices including Forecast Accuracy in 2022. Organon can reduce inventory with practices including Demand Shaping in 2022. Organon can reduce days sales outstanding with practices including in 2022. Organon can increase sales revenue by $$31,176,000,000 improving sales performance to next benchmark tier in 2022. Organon can increase revenue growth by $$0 by improving growth performance to next benchmark tier in 2022. Organon can increase overall revenue by $$31,177,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Organon can increase days payables outstanding with practices including in 2022. Organon can increase days payables outstanding by $0 days by increasing days payables outstanding to next benchmark tier in 2022. Organon can improve total financial performance by $$32,937,000,000 by improving revenue, costs, and working capital in 2022. Organon can decrease overall working capital by $$719,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Organon can decrease inventory days by $406,000,000 days by reducing inventory days to next benchmark tier in 2022. Organon can decrease days sales outstanding by $313,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Organon can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Organon can accelerate revenue growth practices including Pricing Optimization in 2022. Organon can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 82 days was the measured parity or middle performance level for cash to cash cycle time in Organon's peer group in 2022. 79 days was the measured superior or top ten performance level for days of inventory in Organon's peer group in 2022. 68 days was the measured advantage or top third performance level for cash to cash cycle time in Organon's peer group in 2022. 66 days was the measured parity or middle performance level for days sales outstanding in Organon's peer group in 2022. 61 days was the measured advantage or top third performance level for days sales outstanding in Organon's peer group in 2022. 6.73% was the measured superior or top ten performance level for sales volatility in Organon's peer group in 2022. 56 days was the measured superior or top ten performance level for days sales outstanding in Organon's peer group in 2022. 37.46% was the measured superior or top ten performance level for gross margin in Organon's peer group in 2022. 37 days was the measured superior or top ten performance level for cash to cash cycle time in Organon's peer group in 2022. 26.85% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Organon's peer group in 2022. 22.98% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Organon's peer group in 2022. 21.84% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Organon's peer group in 2022. 14.35% was the measured parity or middle performance level for sales volatility in Organon's peer group in 2022. 129 days was the measured parity or middle performance level for days of inventory in Organon's peer group in 2022. 100 days was the measured advantage or top third performance level for days of inventory in Organon's peer group in 2022. 10.93% was the measured advantage or top third performance level for sales volatility in Organon's peer group in 2022. 0.03% was the measured superior or top ten performance level for sales growth in Organon's peer group in 2022. 0.00% was the measured advantage or top third performance level for sales growth in Organon's peer group in 2022. -0.01% was the measured parity or middle performance level for sales growth in Organon's peer group in 2022. $33.59% was the measured advantage or top third performance level for gross margin in Organon's peer group in 2022. $30.58% was the measured parity or middle performance level for gross margin in Organon's peer group in 2022. $$95,482,000,000 was the measured superior or top ten performance level for gross revenue in Organon's peer group in 2022. $$58,423,000,000 was the measured advantage or top third performance level for gross revenue in Organon's peer group. $$37,350,000,000 was the measured parity or middle performance level for gross revenue in Organon's peer group in 2022.